[go: up one dir, main page]

MX2012011207A - Combinations for treating obstructive diseases in airways. - Google Patents

Combinations for treating obstructive diseases in airways.

Info

Publication number
MX2012011207A
MX2012011207A MX2012011207A MX2012011207A MX2012011207A MX 2012011207 A MX2012011207 A MX 2012011207A MX 2012011207 A MX2012011207 A MX 2012011207A MX 2012011207 A MX2012011207 A MX 2012011207A MX 2012011207 A MX2012011207 A MX 2012011207A
Authority
MX
Mexico
Prior art keywords
airways
combinations
treating obstructive
obstructive diseases
diseases
Prior art date
Application number
MX2012011207A
Other languages
Spanish (es)
Inventor
Lorenzo Pérez Pérez
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Priority to MX2012011207A priority Critical patent/MX2012011207A/en
Publication of MX2012011207A publication Critical patent/MX2012011207A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention shows compositions of a beta-2 antagonist and a steroid and the use thereof for treating obstructive diseases of airways.
MX2012011207A 2012-09-27 2012-09-27 Combinations for treating obstructive diseases in airways. MX2012011207A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012011207A MX2012011207A (en) 2012-09-27 2012-09-27 Combinations for treating obstructive diseases in airways.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012011207A MX2012011207A (en) 2012-09-27 2012-09-27 Combinations for treating obstructive diseases in airways.

Publications (1)

Publication Number Publication Date
MX2012011207A true MX2012011207A (en) 2014-03-27

Family

ID=50935183

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012011207A MX2012011207A (en) 2012-09-27 2012-09-27 Combinations for treating obstructive diseases in airways.

Country Status (1)

Country Link
MX (1) MX2012011207A (en)

Similar Documents

Publication Publication Date Title
IL266582A (en) Compositions and methods for the treatment of hemoglobinopathies
HUE041553T2 (en) Methods and compositions for the treatment of monogenic diseases
IL239355A0 (en) Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
IL237258A0 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
IL233744A0 (en) Neuroactive steroid formulations and methods of treating cns disorders
EP2675469A4 (en) Compositions, devices and methods of use thereof for the treatment of cancers
ZA201506682B (en) Compositions and methods for the improved production and delivery of rna
EP3043824A4 (en) Modified therapeutic agents and compositions thereof
IL245674A0 (en) Methods and compositions for the targeted modification of a genome
IL246020A0 (en) Compositions and methods for phagocyte delivery of anti-staphylococcal agents
DK3292875T3 (en) Compositions and methods for treating diseases
MX365242B (en) Use of cxcr4 antagonists.
IL233639A0 (en) Compositions and methods for the treatment of hepatic diseases and disorders
ZA201403431B (en) Pharmaceutical compositions and methods of use of 4-pregenen-11b-21-triol-3,20-dione derivatives
MX2014000878A (en) Compositions and methods for reducing the incidence of equine digestive disorders.
SG11201505431XA (en) Therapeutic compositions and methods involving mrna transfection
IL238415A0 (en) Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e
HRP20181632T1 (en) Methods and compositions for the targeted modification of a genome
MX2012011207A (en) Combinations for treating obstructive diseases in airways.
IL271284A (en) Methods for treating or preventing asthma by administering an il-4r antagonist